Chitosan nanoparticles as a potential nonviral gene delivery for HPV-16 E7 into mammalian cells
Source abstract
Abstract
Chitosan nanoparticles (CS NPs) were prepared as a carrier for Human papillomavirus type 16 HPV-16) E7 gene and their gene transfection ability were evaluated in vitro. The plasmid expressing green fluorescent protein (pEGFP) was used as a reporter gene. Gel electrophoresis demonstrated full binding of CS NPs with the pDNA. The transfection of CS-pEGFP NPs was efficient in CHO cells and the expression of green fluorescent proteins was well observed. The expression of E7 proteins was confirmed under SDS-PAGE and western blot analysis. As a conclusion CS NPs may serve as an effective nonviral carrier for delivery of nucleotides into eukaryotic cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Virus-based gene therapy research · Animal Virus Infections Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (29)
Show source-provided references
1. 10.1016/j.jconrel.2004.08.01010.1016/j.jconrel.2004.08.010 ↗
2. 10.1016/j.nano.2010.01.01110.1016/j.nano.2010.01.011 ↗
3. 10.1016/j.carbpol.2008.01.01510.1016/j.carbpol.2008.01.015 ↗
4. 10.1093/jnci/87.11.79610.1093/jnci/87.11.796 ↗
5. 10.1080/1071754049028070510.1080/10717540490280705 ↗
6. Chen CH · Cancer Res · 2000 · 60 · 1035
7. 10.1021/bm034502r10.1021/bm034502r ↗
8. Duggan MA · Eur J Gynaecol Oncol · 1998 · 19 · 338
9. 10.1007/978-1-61779-480-3_410.1007/978-1-61779-480-3_4 ↗
10. Ferber D · Safer and virus-free? Science · 2001 · 294 · 1638
11. 10.1186/1479-0556-8-310.1186/1479-0556-8-3 ↗
12. 10.1159/00032019710.1159/000320197 ↗
13. Hallaj-Nezhadi S · J Pharm Pharm Sci · 2011 · 14 · 18110.18433/J3TP4T ↗
14. 10.1016/j.carbpol.2009.08.02610.1016/j.carbpol.2009.08.026 ↗
15. 10.1016/j.biomaterials.2006.04.02910.1016/j.biomaterials.2006.04.029 ↗
16. 10.1016/j.addr.2009.08.00410.1016/j.addr.2009.08.004 ↗
17. 10.1016/S0065-2776(00)75006-110.1016/S0065-2776(00)75006-1 ↗
18. 10.1055/s-0032-133116510.1055/s-0032-1331165 ↗
19. 10.1016/S0142-9612(98)00159-810.1016/S0142-9612(98)00159-8 ↗
20. 10.1016/S0169-409X(00)00133-210.1016/S0169-409X(00)00133-2 ↗
21. 10.1016/j.ijpharm.2010.08.02210.1016/j.ijpharm.2010.08.022 ↗
22. 10.1038/3503853310.1038/35038533 ↗
23. 10.1016/j.ejpb.2003.09.00610.1016/j.ejpb.2003.09.006 ↗
24. 10.1016/j.actatropica.2013.07.01310.1016/j.actatropica.2013.07.013 ↗
25. 10.1016/j.ijpharm.2007.07.01110.1016/j.ijpharm.2007.07.011 ↗
26. 10.1016/j.ijpharm.2005.01.04210.1016/j.ijpharm.2005.01.042 ↗
27. Yousefpour P · Daru · 2011 · 19 · 367
28. 10.1093/abbs/gmp03810.1093/abbs/gmp038 ↗
29. zur Hausen H · Biochim Biophys Acta · 1996 · 1288 · 55